ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has created new posts for Drug Inspectors for efficient market surveillance. DRAP has taken concrete steps for strengthening its systems to ensure public access to quality and safe medicines, spokesperson said. DRAP is adopting best practices to become a modern day regulatory body. In order to eradicate menace of spurious, smuggled and unregistered medicine from market and protect public, DRAP has created 25 posts for Federal Inspectors of drugs to be posted throughout the country. A roadmap has been prepared for training of these inspectors according to international standards of Good Manufacturing Practices (GMP), sample collection and market surveillance. In this regard, DRAP has implemented Integrated Regulatory Information Management System (IRIMS) for online submission of fee, registration application, renewal of registration for drugs and post registration variations. Pharmaceutical companies would be able to submit requisite information to DRAP through this system. The implementation of IRIMS is aimed to ensure complete transparency in operations at DRAP. Pharmaceutical companies were trained by DRAP team on the submission system in various workshops held at Karachi, Islamabad, Lahore and Peshawar.